Author:
Pillai Raju K.,Nathwani Bharat N.,Yang Lixin
Publisher
Springer International Publishing
Reference31 articles.
1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al. WHO classification of tumors of hematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2017.
2. Onaindia A, Medeiros LJ, Patel KP. Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms. Mod Pathol Off J U S Can Acad Pathol Inc. 2017;30(10):1338–66. PubMed PMID: 28664939.
3. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010;463(7277):88–92. PubMed PMID: 20054396. Pubmed Central PMCID: 2845535.
4. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008;319(5870):1676–9. PubMed PMID: 18323416.
5. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44(12):1321–5. PubMed PMID: 23143597. Pubmed Central PMCID: 3674561.